Chronic Headaches and the Neurobiology of Somatization
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Pain Management of Inmates
PAIN MANAGEMENT OF INMATES Federal Bureau of Prisons Clinical Guidance JUNE 2018 Federal Bureau of Prisons (BOP) Clinical Guidance is made available to the public for informational purposes only. The BOP does not warrant this guidance for any other purpose, and assumes no responsibility for any injury or damage resulting from the reliance thereof. Proper medical practice necessitates that all cases are evaluated on an individual basis and that treatment decisions are patient- specific. Consult the BOP Health Management Resources Web page to determine the date of the most recent update to this document: http://www.bop.gov/resources/health_care_mngmt.jsp Federal Bureau of Prisons Pain Management of Inmates Clinical Guidance June 2018 TABLE OF CONTENTS 1. PURPOSE OF THIS GUIDANCE.................................................................................................................. 1 2. INTRODUCTION TO PAIN MANAGEMENT IN THE BOP .................................................................................. 1 The Prevalence of Chronic Pain ........................................................................................................ 1 General Principles of Pain Management in the BOP .......................................................................... 2 Multiple Dimensions of Pain Management ................................................................................... 2 Interdisciplinary Pain Rehabilitation (IPR) .................................................................................... 2 Roles -
DSM-IV Pain Disorder in the General Population an Exploration of the Structure and Threshold of Medically Unexplained Pain Symptoms
DSM-IV pain disorder in the general population An exploration of the structure and threshold of medically unexplained pain symptoms Christine Fröhlich,· Frank Jacobi, Hans-Ulrich Wittchen Received: 18 March 2005 / Accepted: 12 September 2005 / Published online: 18 November 2005 Abstract Background Despite an abundance of questionnaire data, the prevalence of clinically significant and medically unexplained pain syndromes in the general population has rarely been examined with a rigid personal-interview methodology. Objective To examine the prevalence of pain syndromes and DSM- IV pain disorder in the general population and the association with other mental disorders, as well as effects on disability and health-care utilization. Methods Analyses were based on a community sample of 4.181 participants 18–65 years old; diagnostic variables were assessed with a standardized diagnostic interview (M-CIDI). Results The 12-month prevalence for DSM-IV pain disorder in the general population was 8.1%; more than 53% showed concurrent anxiety and mood disorders. Subjects with pain disorder revealed significantly poorer quality of life, greater disability, and higher health-care utilization rates compared to cases with pain below the diagnostic threshold. The majority had more than one type of pain, with excessive headache being the most frequent type. Conclusions Even when stringent diagnostic criteria are used, pain disorder ranks among the most prevalent conditions in the community. The joint effects of high prevalence in all age groups, substantial disability, and increased health services utilization result in a substantial total burden, exceeding that of depression and anxiety. Key words: DSM-IV pain disorder, pain syndromes, comorbidity, impairment, Composite International Diagnostic Interview (CIDI) Introduction Chronic pain is well known as a highly prevalent condition in the general population. -
Fibromyalgia in Migraine: a Retrospective Cohort Study Mark Whealy1* , Sanjeev Nanda2, Ann Vincent2, Jay Mandrekar3 and F
Whealy et al. The Journal of Headache and Pain (2018) 19:61 The Journal of Headache https://doi.org/10.1186/s10194-018-0892-9 and Pain SHORT REPORT Open Access Fibromyalgia in migraine: a retrospective cohort study Mark Whealy1* , Sanjeev Nanda2, Ann Vincent2, Jay Mandrekar3 and F. Michael Cutrer1 Abstract Background: Migraine is a common and disabling disorder. Fibromyalgia has been shown to be commonly comorbid in patients with migraine and can intensify disability. The aim of this study was to determine if patients with co-morbid fibromyalgia and migraine report more depressive symptoms, have more headache related disability, or report higher intensity of headache as compared to patients with migraine only. Cases of comorbid fibromyalgia and migraine were identified using a prospectively maintained headache database at Mayo Clinic Rochester. One-hundred and fifty seven cases and 471 controls were identified using this database and the Mayo Clinic electronic medical record. Findings: Depressive symptoms as assessed by PHQ-9, intensity of headache, and migraine related disability as assessed by MIDAS were primary measures used to compare migraine patients with comorbid fibromyalgia versus those without. Patients with comorbid fibromyalgia reported significantly higher PHQ-9 scores (OR 1.08, p < .0001) and headache intensity scores (OR 1.149, p = .007). There was no significant difference in migraine related disability (OR 1.002, p = .075). Patients with fibromyalgia were more likely to score in a higher category of depression severity (OR 1.467, p < .0001) and more likely to score in a higher category of migraine related disability (OR 1.23, p = .004). -
Treating Somatization
TREATING SOMATIZATION TREATING SOMATIZATION A Cognitive-Behavioral Approach Robert L. Woolfolk Lesley A. Allen THE GUILFORD PRESS New York London © 2007 The Guilford Press A Division of Guilford Publications, Inc. 72 Spring Street, New York, NY 10012 www.guilford.com All rights reserved Except as indicated, no part of this book may be reproduced, translated, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise, without written permission from the Publisher. Printed in the United States of America This book is printed on acid-free paper. Last digit is print number:987654321 LIMITED PHOTOCOPY LICENSE These materials are intended for use only by qualified mental health profes- sionals. The Publisher grants to individual purchasers of this book nonassignable permission to reproduce all materials for which photocopying permission is specifically granted in a footnote. This license is limited to you, the individ- ual purchaser, for use with your own clients and patients. It does not extend to additional clinicians or practice settings, nor does purchase by an institu- tion constitute a site license. This license does not grant the right to reproduce these materials for resale, redistribution, or any other purposes (including but not limited to books, pamphlets, articles, video- or audiotapes, and hand- outs or slides for lectures or workshops). Permission to reproduce these materials for these and any other purposes must be obtained in writing from the Permissions Department of Guilford Publications. Library of Congress Cataloging-in-Publication Data Woolfolk, Robert L. Treating somatization : a cognitive-behavioral approach / by Robert L. -
Investigating Correlations Between Defence Mechanisms and Pathological Personality Characteristics
rev colomb psiquiat. 2019;48(4):232–243 www.elsevier.es/rcp Artículo original Investigating Correlations Between Defence Mechanisms and Pathological Personality Characteristics Lucas de Francisco Carvalho ∗, Ana Maria Reis, Giselle Pianowski Department of Psicology, Universidade São Francisco, Campinas, São Paulo, Brazil article info abstract Article history: Introduction: The purpose of this study was to investigate the relationship between defence Received 4 October 2017 mechanisms and pathological personality traits. Accepted 10 January 2018 Material and methods: We analysed 320 participants aged from 18 to 64 years (70.6% women, Available online 10 February 2018 87.5% university students) who completed the Dimensional Clinical Personality Inventory (IDCP) and the Defence Style Questionnaire (DSQ-40). We conducted comparisons and cor- Keywords: relations and a regression analysis. Personality disorders Results: The results showed expressive differences (d>1.0) between mature, neurotic and Defence mechanisms immature defence mechanism groups, and it was observed that pathological personality Self-assessment traits are more typical in people who use less mature defence mechanisms (i.e., neurotic and immature), which comprises marked personality profiles for each group, according to the IDCP. We also found correlations between some of the 40 specific mechanisms of the DSQ-40 and the 12 dimensions of pathological personality traits from the IDCP (r ≥ 0.30 to r ≤ 0.43), partially supported by the literature. In addition, we used regression analysis to verify the potential of the IDCP dimension clusters (related to personality disorders) to predict defence mechanisms, revealing some minimally expressive predictive values (between 20% and 35%). Discussion: The results indicate that those who tend to use immature defence mechanisms are also those most likely to present pathological personality traits. -
Defense Mechanisms.Pdf
Defense Mechanisms According to Sigmund Freud, who originated the Defense Mechanism theory, Defense Mechanisms occur when our ego cannot meet the demands of reality. They are psychological strategies brought into play by the unconscious mind to manipulate, deny or distort reality so as to maintain a socially acceptable self-image. Healthy people normally use these mechanisms throughout life. it becomes pathological only when its persistent use leads to maladaptive behavior such that the physical and/or mental health of the individual is adversely affected. The purpose of ego defense mechanisms is to protect the mind/self/ego from anxiety and/or social sanctions and/or to provide a refuge from a situation with which one cannot currently cope. Defense mechanisms are unconscious coping mechanisms that reduce anxiety generated by threats from unacceptable impulses In 1977, psychologist George Vaillant took Freud’s theory and built upon it by categorizing them, placing Freud’s mechanisms on a continuum related to their psychoanalytical developmental level. Level 1: Pathological Defenses The mechanisms on this level, when predominating, almost always are severely pathological. These six defense’s, in conjunction, permit one to effectively rearrange external experiences to eliminate the need to cope with reality. The pathological users of these mechanisms frequently appear irrational or insane to others. These are the "psychotic" defense’s, common in overt psychosis. However, they are found in dreams and throughout childhood as well. They include: Delusional Projection: Delusions about external reality, usually of a persecutory nature. Conversion: the expression of an intra-psychic conflict as a physical symptom; some examples include blindness, deafness, paralysis, or numbness. -
Factsheet: Chronic Pain and Related Functional Impairment Interagency Collaboration
SHNIC Specialized Health Needs Factsheet: Chronic Pain and Related Functional Impairment Interagency Collaboration What is it? Pediatric chronic can present in a variety of ways and often overlaps with psychological effects. It represents a developmental health issues because of its ability to significantly impair a student’s functional ability. Chronic pain can be persistent and episodic with both an underlying health condition (E.g. Sickle cell disease) and pain that is the pain disorder itself (E.g. Complex Regional Pain Disorder.) The symptoms extend beyond the expected healing period and is commonly described as persisting for at least 3 months. The three most common pain disorders in children include primary headaches, abdominal pain, and recurrent musculoskeletal and joint pain. A child’s developmental perspective affects how he/she will perceive and respond to pain. Psychological variables influencing pain prevalence include anxiety, depression, low self esteem, low socio-economic status, and other chronic health conditions. Chronic pain may peak during adolescence; related to puberty and the physical, emotional, social, and cognitive changes during this stage. Pediatric chronic pain can affect all aspects of daily living including appetite, sleep, socialization, school attendance, academic performance, and peer relationships. A child’s perception of pain and response to pain can also be influenced by parental characteristics like emotional function, behavior, health history, and environment. Pediatric chronic pain can also surface without clear medical evidence to a broader syndrome or condition. Functional somatic symptoms, like pain and fatigue, are physical symptoms not fully explained by a well-defined medical psychiatric or somatic illness. A growing number of patients are seeking pain treatments for sensory processing disorders. -
Chronic Pelvic Pain & Pelvic Floor Myalgia Updated
Welcome to the chronic pelvic pain and pelvic floor myalgia lecture. My name is Dr. Maria Giroux. I am an Obstetrics and Gynecology resident interested in urogynecology. This lecture was created with Dr. Rashmi Bhargava and Dr. Huse Kamencic, who are gynecologists, and Suzanne Funk, a pelvic floor physiotherapist in Regina, Saskatchewan, Canada. We designed a multidisciplinary training program for teaching the assessment of the pelvic floor musculature to identify a possible muscular cause or contribution to chronic pelvic pain and provide early referral for appropriate treatment. We then performed a randomized trial to compare the effectiveness of hands-on vs video-based training methods. The results of this research study will be presented at the AUGS/IUGA Joint Scientific Meeting in Nashville in September 2019. We found both hands-on and video-based training methods are effective. There was no difference in the degree of improvement in assessment scores between the 2 methods. Participants found the training program to be useful for clinical practice. For both versions, we have designed a ”Guide to the Assessment of the Pelvic Floor Musculature,” which are cards with the anatomy of the pelvic floor and step-by step instructions of how to perform the assessment. In this lecture, we present the video-based training program. We have also created a workshop for the hands-on version. For more information about our research and workshop, please visit the website below. This lecture is designed for residents, fellows, general gynecologists, -
Pain: Assessment, Non-Opioid Treatment Approaches and Opioid Management
Health Care Guideline Pain: Assessment, Non-Opioid Treatment Approaches and Opioid Management How to Cite this Document Hooten M, Thorson D, Bianco J, Bonte B, Clavel Jr A, Hora J, Johnson C, Kirksson E, Noonan MP, Reznikoff C, Schweim K, Wainio J, Walker N. Institute for Clinical Systems Improvement. Pain: Assess- ment, Non-Opioid Treatment Approaches and Opioid Management. Updated August 2017. ICSI Members, Sponsors and organizations delivering care within Minnesota borders, may use ICSI documents in the following ways: • ICSI Health Care Guidelines and related products (hereinafter “Guidelines”) may be used and distributed by ICSI Member and Sponsor organizations as well as organizations delivering care within Minnesota borders. The guidelines can be used and distributed within the organization, to employees and anyone involved in the organization’s process for developing and implementing clinical guidelines. • ICSI Sponsor organizations can distribute the Guidelines to their enrollees and those care delivery organizations a sponsor holds insurance contracts with. • Guidelines may not be distributed outside of the organization, for any other purpose, without prior written consent from ICSI. • The Guidelines may be used only for the purpose of improving the health and health care of Member’s or Sponsor’s own enrollees and/or patients. • Only ICSI Members and Sponsors may adopt or adapt the Guidelines for use within their organizations. • Consent must be obtained from ICSI to prepare derivative works based on the Guidelines. • Appropriate attribution must be given to ICSI on any and all print or electronic documents that reference the Guidelines. All other copyright rights for ICSI Health Care Guidelines are reserved by the Institute for Clinical Systems Improvement. -
Co-Players in Chronic Pain: Neuroinflammation and the Tryp- Tophan-Kynurenine Metabolic Pathway
Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 4 June 2021 doi:10.20944/preprints202106.0128.v1 Review Co-players in Chronic Pain: Neuroinflammation and the Tryp- tophan-Kynurenine Metabolic Pathway Masaru Tanaka1,2, Nóra Török1,2, Fanni Tóth2, László Vécsei1,2,* 1 MTA-SZTE, Neuroscience Research Group, Semmelweis u. 6, Szeged, H-6725 Hungary 2 Department of Neurology, Interdisciplinary Excellence Centre, Faculty of Medicine, University of Szeged, Semmelweis u. 6, H-6725 Szeged, Hungary * Correspondence: [email protected]; Tel.: +36-62-545-351 Abstract: Chronic pain is an unpleasant sensory and emotional experience that persists or recurs more than three months and may extend beyond the expected time of healing. Recently nociplastic pain has been introduced as a descriptor of mechanism of pain, which is due to disturbance of neural processing without actual or potential tissue damage, appearing to replace a concept of psychogenic pain. An interdisciplinary task force of the International Association for the Study of Pain (IASP) compiled a systematic classification of clinical conditions associated with chronic pain, which was published in 2018 and will officially come into effect in 2022 in the 11th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-11) by the World Health Organization. ICD-11 offers the option for recording the presence of psychological or social factors in chronic pain; however, cognitive, emotional, and social dimensions in the patho- genesis of chronic pain are missing. Earlier pain disorder was defined as a condition with chronic pain associated with psychological factors, but it was replaced with somatic symptom disorder with predominant pain in Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) in 2013. -
Hypochondriasis and Somatization Disorder
Ch14.qxd 28/6/07 1:36 PM Page 152 14 Hypochondriasis and Somatization Disorder Don R. Lipsitt CONTENTS 14.1 The Concept of Somatization . 153 14.2 Classification . 154 14.2.1 From DSM-I to DSM-III . 154 14.2.2 Case History (Part 1). 155 14.3 Diagnosis . 156 14.3.1 Hypochondriasis . 156 14.3.2 Somatization Disorder . 160 14.3.3 Case History (Part 2). 163 14.4 The Consultation-Liaison Psychiatrist’s Role in Somatization . 163 14.5 Conclusion . 164 On a busy day in a general physician’s office, perhaps 50% or more of the patients with physical complaints will have no definitive explanation for their ailment (Kroenke and Mangelsdorff, 1989). The patients present with distress from fatigue, chest pain, cough, back pain, shortness of breath, and a host of other painful or worrisome bodily concerns. For most, the physician’s expressing interest, taking a thorough history, doing a physical examination, and offering reassurance, a mod- est intervention, or a pharmacologic prescription suffices to assuage the patient’s pain, anxiety, and physical distress. But for some, these simple measures fall short of their expected result, marking the beginning of what may become a chronic search for relief, including frequent anxiety-filled visits to more than one physician, and in extreme cases even multiple hospitalizations and possibly surgery. The longer and more persistently this pattern appears, the more likely it will generate referrals to specialists for expert consultation, greater frustration in both the primary physician and the patient, and ultimately dysfunctional patient–physician relationships with inappropriate labeling of the patient as a “problem” or “difficult” patient, and perhaps even worse (Lipsitt, 1970). -
Pain Management Clinical Practice Guideline Hs-1064
PAIN MANAGEMENT CLINICAL PRACTICE GUIDELINE HS-1064 Pain Management Clinical Practice Guideline OBJECTIVE The objective of this Clinical Practice Guideline (CPG) is to provide evidence-based practice recommendations for the management of pain. The CPG discusses the assessment and treatment of acute and chronic, neuropathic and nociceptive pain, as well as behavioral health implications of chronic pain. In addition, the CPG outlines the organizations that WellCare aligns with regarding pain management and relevant Measurements of Compliance and Measureable Health Outcomes. WellCare has a separate “Palliative Care (HS-1045)” Clinical Practice Guideline that more broadly addresses best-practices for improving quality of life and anticipating/minimizing suffering caused by a chronic and / or life-threatening illness. OVERVIEW Pain is cited as the most common reason Americans seek health care and is a major contributor to health care costs. Approximately one in every four Americans has suffered from pain lasting longer than 24 hours, and an estimated 25 million adults (11%) have reported a pain event that occurred every day for at least a 3-month period. Chronic pain is the most common cause of long-term disability.1,2 Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage."3 The characterization of pain as a temporal process (continuum of pain) begins with an acute stage and potentially progresses to a chronic state:4 • Acute pain: a time limited and expected physiologic effect of trauma, disease, surgery or illness that may progress to a chronic pathological state4 • Chronic Pain: a complex biopsychosocial condition that has a distinct pathology with biological, psychological, and cognitive correlates that may interfere with many aspects of a person’s life (high impact chronic pain)4 Pain is categorized along various dimensions; one of the most useful is the division of nociceptive vs.